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Many pathological conditions are accompanied with changes in the concentration of
the total IgG or some of its fraction. For this reason there is great interest in the production of
reagents specific for IgG. In this paper, the binding characteristics of two new murine
monoclonal antibodies (MoAb), assigned MoAb 15 and MoAb 22, are reported. These
MoAbs were produced by hybridoma technology. By performing ELISAs and Western
blots analyzes, it was demonstrated that both MoAbs interact specifically with human IgG.
Cross reactivity with other sera proteins was not observed. In order to precisely localize the
epitopes recognized by MoAb 15 and MoAb 22, the Western blots interactions of these
MoAbs with electrophoreticaly separated IgG-fragments, obtained by the action of pro-
teolytic enzymes (papain, pepsin, trypsin), were analyzed. According to the results of these
experiments, both MoAbs interacted with epitopes in the C 3 domain. The affinity con-
stants, calculated from Scatchard plots of binding of MoAb 15 and MoAb 22 to human IgG,
were Ka15 = 1.71 106 M-1 and Ka22 = 2.15 109 M-1. According to all these findings, MoAb
15 and MoAb 22 could be used in standard immunochemical techniques. However, the ex-
periments showed that both MoAbs had bad immunoprecipitating properties. In solid phase
techniques (ELISAs, Western blot, dot-blot, etc.), their application gave excellent results
that highly recommended them for use in these types of analyzes.
Keywords: human IgG, affinity constant, murine monoclonal antibodies, immuno-
chemical technique.
INTRODUCTION
Hybridoma technology, designed by G. Kohler and C. Milstain in 1975,1 is the
oldest way to produce monoclonal antibodies (MoAb) with the desired binding charac-
teristics. This protocol enabled the production of, theoretically, unlimited variety source
of homogenous amounts of MoAbs with “predefined” characteristics of binding (affin-
ity and specificity). In spite of the development of new technologies based on methods
of genetic engineering,2 this procedure is still widely used.
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After the appearance of hybridoma technology, MoAbs became the “reagents of
choice” in research and diagnostic. The application of MoAbs made standard procedures
more specific and more sensitive.3 However, each application of MoAbs required its de-
tailed characterization as a guarantee for the validity of the obtained results. So, expression
“to produce MoAb-reagents” meant to obtain a MoAb and to fully characterize it.
Our goal was the production of MoAbs specific for human IgG (hIgG). Interest in
the production of reagents specific for IgG can be explained by the fact that many
pathological conditions are accompanied by changes in the concentration of the total
IgG or some of its fractions.4
In this paper, investigations on the binding characteristics of two new murine
MoAbs produced by hybridoma technology, assigned MoAb 15 and MoAb 22, are
described. The investigations showed that they reacted specifically with hIgG, a fact
that could make them usefull, primarily as diagnostic tools.
EXPERIMENTAL
Determination of affinity of MoAb 15 and MoAb 22 for hIgG by competitive ELISA
Affinity constants (Ka) of MoAb 15 and MoAb 22 were calculated, according to Scatchard ana-
lyze, from the results obtained by competitive ELISA. In this experiment, a constant amount (1  g/ml
i.e., 6.4 nM) of MoAb labeled by biotin (MoAb-B) was incubated in the presence of different concen-
trations of hIgG for 2 h at 25 ºC. Determination of the concentrations of free MoAb (F) in these samples
were based on binding to hIgG adsorbed on microtitar plate, while the concentrations of MoAb 15 and
MoAb 22 bound to hIgG in solution (B) were equal to the differences between the total MoAb concen-
tration and F.
For determination of F15 and F22, hIgG was adsorbed on microtitar plates from hIgG/PBS so-
lution at concentrations of 0.5  g/ml and 1  g/ml, respectively (50  l/well, at 4 ºC, over night). A so-
lution of 1 % BSA(Sigma)/PBS was used for saturation (200  l/well, 2 h, at room temperature), prep-
aration of samples and dilution of streptavidin-peroxidase (ICN) (50  l/well, 1 h, 25 ºC). Before each
step, following saturation, the plates were washed with 0.05 % Tween 20 (Sigma)/PBS (4 200
 l/well) and PBS (1   l/well). OPD (Sigma) (50  l/well) was used as substrate and its transfor-
mation by streptavidin-peroxidase was stopped by adding 2 M H2SO4 (50  l/well). The amount of
MoAb-B bound to hIgG adsorbed on the plates was proportional to the absorbance read at 492 nm.
Fragmentation of hIgG by:
a) papain
Fragmentation of hIgG by papain was performed in 0.1 M Na-phosphate buffer, pH 6.5, in the
presence of 50 mM Cys (Merck) and 1 mM EDTA(Fluka). The final ratio of masses of hIgG and papain
(Gibco BRL) (mhIgG : mpapain) was 100 : 1. The digestive mixture was incubated at 37 ºC for  16 h.
The reaction was stopped by adding a solution of iodacetamide to a final concentration of 75 mM.
b) pepsin
Fragmentation of hIgG by pepsin was performed in 0.1 M acetic buffer, pH 3.5, at 37 ºC. The
ratio of the amount of hIgG and pepsin (Sigma) in the digestion mixture was mhIgG : mpepsin = 100 : 1.
The reaction was stopped in intervals of 1 h by raising the pH to 9.
c) trypsin
Fragmentation of the isolated Fc portion of hIgG (hFc) by trypsin was performed in 10 mM
Tris / 0.1 M NaCl, pH 7.8, at 40 ºC for  1 h. Before the addition of trypsin, the pH of the hFc solution
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was lowered to 2.5 by adding 2 M HCl. The solution was incubated for  5 min and the pH was re-
turned to 7.8 by adding 1 M Tris. The ratio of hFc and trypsin in the reaction mixture was mhFc :
mtrypsin = 100 : 2.
RESULTS AND DISCUSSION
Murine hybridoma 15 and 22, which secreted MoAb 15 and MoAb 22, respec-
tively, were obtained by fusion of murine mieloma cells SP/02 mIL-6 and spleen cells
of BALB/c mouse immunized with hIgG. Preliminary tests, performed with super-
natant of clones 15 and 22, indicated that MoAb 15 and MoAb 22 interacted with hIgG.
Further investigations, performed with MoAb 15 and MoAb 22 isolated from appropri-
ate ascitic fluids, confirmed this observation.
Affinity of MoAb 15 and MoAb 22 for hIgG
The affinity of MoAb for its Ag is one of the most important properties determin-
ing its usefulness.5 The affinities of MoAb 15 (Ka15) and MoAb 22 (Ka22) for hIgG
were determined by competitive ELISA. In these experiments, the binding of MoAb 15
and MoAb 22 (both at constant concentration, 1  g/ml) to hIgG adsorbed on microtitar
plate were inhibited by incubation with different amounts of hIgG. The obtained results
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Fig. 1. Scatchard plots (B/F = f(B))
for the binding of MoAb 15 a) and
MoAb 22 b) to hIgG; B – concen-
tration of MoAb bound to hIgG, F
– concentration of free MoAb.
were transformed according to the Scatchard equation and the value of Ka was deter-
mined from Scatchard plot (Fig. 1). Ka values of MoAb 15 and MoAb 22 for hIgG are:
Ka15 = 1.71  106 M–1 and Ka22 = 2.15  109 M–1, respectively.
According to its affinity for hIgG, MoAb 22 might be used, after coupling to an
inert matrix, for the isolation of hIgG by affinity chromatography, ELISA, Western blot,
dot-blot, immunofluorescence and in different forms of immunoprecipitation.5 How-
ever, MoAb 22, despite of high affinity, had bad immunoprecipitation characteristics
and did not precipitate hIgG either in solution or in agarose gel. Steric hindrances or
functional monovalency6 that would prevent the formation of an immunoprecipitation
lattice could be the explanations of this phenomenon.
The Ka15 value of MoAb 15 implied that it could be used in tests such as ELISA
and Western blot, too.5 However, it also showed bad immunoprecipitation properties,
most probably, because of its low affinity for hIgG.
Localization of the epitopees recognized by MoAb 15 and MoAb 22
Western blot analyzes of electrophoreticaly separated human sera proteins,
showed that both MoAbs reacted with the heavy  chain of human immunoglobulins
(Fig. 2). According to the results of these experiments, the reactivity of MoAb 15 and
MoAb 22 with other, “non-IgG”, sera proteins could also be excluded. The non-existe-
nce of cross-reactivity is very important if these MoAbs are to be used for the quantifi-
cation of hIgG.
The determination of the concentration of hIgG is usually performed by different
types of ELISAs. We showed that both MoAbs could be used successively in these as-
says. Using MoAb 15 or MoAb 22, less than 1  g/ml of hIgG could be detected by
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Fig. 2. SDS-PAGE in 4 – 15 % PAAG a) and Western blot analyzes of 1 – human sera, 2 – hIgG, 3 –
hIgG reduced with  -mercaptoethanol, 4 – hIgA reduced with  -mercaptoethanol 5 – hIgM reduced
with  -mercaptoethanol; blots were developed in presence of MoAb 22 (b) and MoAb 15 (c).
ELISA. The low value of the additivity index (AI)7 for MoAb 15 and MoAb 22, AI15,22
= 6.22, indicated that these MoAbs, because of steric hindrance for the simultaneous
binding on hIgG, could not be used in sandwich ELISA which is more specific than oth-
ers types of ELISAs. In “sandwich” ELISA they could be used in combination with
MoAbs that recognize epitopes located far from those of MoAb 15 and MoAb 22. For
example, they could be used with MoAb 44 (specific form human  chain) for the deter-
mination of the concentration of IgG molecules.
In order to localize the epitopes recognized by MoAb 15 and MoAb 22 more pre-
cisely, the interactions of these MoAbs with fragments of hIgG, obtained by the action
of papain, trypsin and pepsin, were analyzed.
The main products of papain digestion of hIgG were fragments of equal molecu-
lar size ( 50 kDa), Fab and Fc.8 They could be separated by affinity chromatography
on protein A.9 The fragments obtained by papain digestion were analyzed by Western
blot. According to the bands on blots of sample eluted from protein A, which appeared
in the presence of both MoAbs (Fig. 3), it was concluded that the epitopes recognized
by MoAb 15 and MoAb 22 were located in the Fc portion of hIgG.
It is well known that peptic digestion of hIgG yields (Fab)2 ( 100 kDa) and pFc’
as the main products. Beside these fragments, numerous intermediate products and
peptides resulting from the enzymatic degradation of C 2 occur in the digestion mix-
ture10 (Fig. 4a). Four major bands appeared on blots developed in the presence of
MoAb 15 (Fig. 4b) or MoAb 22 (Fig. 4a), after electrophoretical separation of the hIgG
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Fig. 3. SDS-PAGE (7.5 % PAAG) of hIgG fragments obtained by the action of papain (c) and
Western blot analyses of the interaction of MoAb 15 (a) and MoAb 22 (b) with them; samples: 1 –
digestive mixture of hIgG resulting from the action of papain, 2 – fraction of the digestive mixture
of hIgG resulting from the action of papain which did not interact with protein A, 3 – fraction of di-
gestive mixture of hIgG resulting from the action of papain which was eluted from protein A by 0.1
M citric buffer, pH 3.5.
fragments obtained by the action of pepsin. These bands, assigned according to corre-
sponding molecular weights, were: “ 100 kDa”, “ 50 kDa”, “ 25 kDa” and “ 15
kDa”. The positions of molecular weights markers in the polyacrylamide gel (PAAG)
indicated that, in this system, resolution of protein with “higher” (>100 kDa) molecular
weight was not correct (Fig. 4a). So, it is possible that “ 100 kDa” bands on blots were
the result of interaction of MoAb 15 or MoAb 22 with intact hIgG or its intermediates
that possesed a partially degraded Fc portion. Regarding the fact that the major cleavage
site of pepsin is in the lower hinge region, below interchain disulphide bonds,10 the ap-
pearance of “ 50 kDa” in the PAAG was unexpected. It is possible that this band was
the result of stochastic formation of disulphide bonds between free Cys residues of frag-
ments produced by the action of pepsin. Interactions with proteins of band “ 25 kDa”
(C 2-C 3) confirmed our finding that epitopes recognized by MoAb 15 and MoAb 22
were located in the Fc portion of hIgG.
Interactions of MoAb 15 and MoAb 22 with peptic bands of lower molecular
weight indicated that epitopes recognized by these MoAbs could be located in the C 3
domain of the human  chain. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blot analyzes of fragments resulting from tryptic digestion of the hFc por-
tion of Ig confirmed this hypothesis. HFc were obtained by papain digestion of hIgG,
isolated by affinity chromatography on protein Aand exposed to low pH (pH 2.5). Ex-
posure to low pH rendered the region between C 2 and C 3 domains transiently
susceptibile to trypsin upon return to neutral pH, allowing the splitting of Fc to those
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Fig. 4. SDS-PAGE (10 % PAAG) of hIgG fragmentized with pepsin (a) and Western blot analyzes
of the interactions of MoAb 15 (b) and MoAb 22 (c) with the obtained fragments; samples: pepsin
at concentration used for digestion (1), intact hIgG (2), mixtures of hIgG fragments obtained by the
action of pepsin for 1 h (3), 2 h (4), 3 h (5), 4 h (6), 6 h (7) and 8 h (8).
two domains.11 After SDS-PAGE of tryptic digestion mixture, there were 3 bands in
PAAG:  25 kDa,  17 kDa and  12.5 kDa (Fig. 5a). Western blot analyzes showed
that both MoAbs reacted with the “ 25 kDa” band (unseparated between C 2-C 3) and
the band of the lowest molecular weight (Fig. 5b, c) which, according to literature data,
represents the C 3 domains.12
Precise localization of epitopes recognized by a MoAb could be useful data in
functional studies, inhibition studies or in designing experiments that require simulta-
neous use of more MoAbs.
CONCLUSION
MoAb 15 and MoAb 22, obtained by hybridoma technology, were specific for
hIgG. They specifically interacted with epitopes localized in the C 3 domain of the hu-
man  chain. The affinity of the interaction of MoAb 22 was high (Ka22 = 2.15 109
M–1), while MoAb 15 bound hIgG with low affinity (Ka15 = 1.71 106 M–1). Accord-
ing to our results, MoAb 15 and MoAb 22 did not precipitate hIgG either in solution or
in agarose gel. This inability to form precipitating complexes with hIgG reduce their
applicability. Otherwise, both MoAbs, when used independently, demonstrated excel-
lent properties in common diagnostic tests such as ELISA, blots, etc. However, in these
assays advantage could be given to MoAb 22 because of its greater affinity that allows
the detection of hIgG at lower concentrations.
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Fig. 5. SDS-PAGE (15 % PAAG) of hFc fragments obtained by the action of trypsin (c) and West-
ern blots analyzes of the interaction of MoAb 15 (b) and MoAb 22 (a) with these fragments; 1 –
hFc fragmentized by trypsin, 2 – hFc exposed to low pH.
I Z V O D
DVA NOVA MI[JA MONOKLONSKA ANTITELA DOBIJENA PROTIV HUMANOG
IgG-a
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DIMITRIJEVI]1
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Mnoga patolo{ka stawa su povezana sa promenama koncentracije ukupnog IgG-a
ili neke od wegovih frakcija. To je razlog velikog interesovawa za produkciju
reagenasa specifi~nih za IgG. Mi smo u ovom radu opisali karakteristike vezivawa
dva nova mi{ja monoklonska antitela (MoAt), ozna~ena kao MoAt 15 i MoAt 22. Ova
MoAt su dobijena hibridomskom tehnologijom. Koriste}i ELISA-e i Western blot ana-
lize, pokazali smo da oba MoAt specifi~no reaguju sa humanim IgG-om. Ukr{tena
reaktivnost sa drugim serumskim proteinima nije uo~ena. Da bi smo precizno loci-
rali epitope koje prepoznaju MoAt 15 i MoAt 22, Western blot-om smo analizirali
interakcije ovih MoAt sa elektroforetski razdvojenim fragmentima IgG-a dobijenih
dejstvom proteoliti~kih enzima (papain, pepsin, tripsin). Prema rezultatima ovih
eksperimenata oba MoAt interreaguju sa epitopima u C 3 domenu. Konstante afi-
niteta, izra~unate sa Ska~ardovih dijagrama vezivawa MoAt 15 i MoAt 22 za humani IgG
su Ka15 = 1.71  106 M–1 i Ka22 = 2.15  109 M–1. Na osnovu svih ovih ~iwenica, MoAt 15 i
MoAt 22 bi se mogla koristiti u standardnim imunohemijskim tehnikama. Me|utim,
na{i eksperimenti su pokazali da oba MoAt imaju lo{e imunoprecipitacione oso-
bine. Sa druge strane, u tehnikama na ~vrstoj fazi (ELISA-e, Western blot, dot-blot, itd.)
wihova primena je dala odli~ne rezultate {to ih preporu~uje za upotrebu u ovom tipu
analiza.
(Primqeno 24. novembra 2000)
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